Skip to main content

Table 5 Prescription of ACT for all patients in post- and pre-RDT implementation areas with ACT in stock at health facility

From: Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests

Characteristic

Ifakara HDSS (pre-mRDT implementation)

Rufiji HDSS (post-mRDT implementation)

P-value (site)

Ā 

n/N

%(95% CI)

n/N

%(95% CI)

Ā 

All patients treated with ACT (overall)

241/587

41.1 (33.4-49.2)

217/666

32.6 (26.5-39.4)

0.10

ā€‚High transmission season (March 2010)

155/332

46.7 (38.9-54.6)

119/349

34.1 (27.9-40.9)

0.02

ā€‚Low transmission season (October 2010)

86/255

33.7 (22.6-47.0)

98/317

30.9 (20.7-43.4)

0.74

Correct treatment: Patients with uncomplicated malaria treated with ACT (overall)

26/37

70.3 (54.7-82.2)

76/94

80.9 (68.2-89.3)

0.22

ā€‚High transmission season (March 2010)

14/24

58.3 (39.4-75.1)

61/71

85.9 (72.0-93.6)

0.01

ā€‚Low transmission season (October 2010)

12/13

92.3 (54.2-99.2)

15/23

65.2 (36.2-86.1)

0.11

Over treatment: Patients without uncomplicated malaria treated with ACT (overall)

215/550

39.1 (31.0-47.8)

141/572

24.7 (18.4-32.2)

0.01

ā€‚High transmission season (March 2010)

141/308

45.8 (37.2-54.6)

58/278

20.9 (14.7-28.8)

<0.01

ā€‚Low transmission season (October 2010)

74/242

30.6 (19.6-44.3)

83/294

28.2 (18.2-41.1)

0.78